The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
The Natural Cytotoxicity Receptors in Health and Disease
Open accessAbstract
The Natural Cytotoxicity Receptors (NCRs), NKp46, NKp44, and NKp30, were some of the first human activating Natural Killer (NK) cell receptors involved in the non-MHC-restricted recognition of tumor cells to be cloned over 20 years ago. Since this time many host- and pathogen-encoded ligands have been proposed to bind the NCRs and regulate the cytotoxic and cytokine-secreting functions of tissue NK cells. This diverse set of NCR ligands can manifest on the surface of tumor or virus-infected cells or can be secreted extracellularly, suggesting a remarkable NCR polyfunctionality that regulates the activity of NK cells in different tissue compartments during steady state or inflammation. Moreover, the NCRs can also be expressed by other innate and adaptive immune cell subsets under certain tissue conditions potentially conferring NK recognition programs to these cells. Here we review NCR biology in health and disease with particular reference to how this important class of receptors regulates the functions of tissue NK cells as well as confer NK cell recognition patterns to other innate and adaptive lymphocyte subsets. Finally, we highlight how NCR biology is being harnessed for novel therapeutic interventions particularly for enhanced tumor surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
Self-citationNuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Kiessling, R., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,824
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Herberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,355
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K. M., Doherty, J. M., Mills, J. C., & Colonna, M. (2009) · Nature · doi:10.1038/nature07537 · Cited by 1,251
Self-citationRecognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., & Porgador, A. (2001) · Nature · doi:10.1038/35059110 · Cited by 990
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Klose, C. S. N., & Artis, D. (2016) · Nature Immunology · doi:10.1038/ni.3489 · Cited by 951
T cell– and B cell–independent adaptive immunity mediated by natural killer cells
O'Leary, J. G., Goodarzi, M., Drayton, D. L., & von Andrian, U. H. (2006) · Nature Immunology · doi:10.1038/ni1332 · Cited by 919
Fuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., Cella, M., & Colonna, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.010 · Cited by 907
Self-citationImmunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904
The PDGF family: four gene products form five dimeric isoforms
Fredriksson, L., Li, H., & Eriksson, U. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.007 · Cited by 838
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
Karlhofer, F. M., Ribaudo, R. K., & Yokoyama, W. M. (1992) · Nature · doi:10.1038/358066a0 · Cited by 797
Schlums, H., Cichocki, F., Tesi, B., Theorell, J., Beziat, V., Holmes, T. D., Han, H., Chiang, S. C. C., Foley, B., Mattsson, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.008 · Cited by 787
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Colonna, M., & Samaridis, J. (1995) · Science · doi:10.1126/science.7716543 · Cited by 736
Self-citationBrandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 706
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
Ahola-Olli, A. V., Würtz, P., Havulinna, A. S., Aalto, K., Pitkänen, N., Lehtimäki, T., Kähönen, M., Lyytikäinen, L.-P., Raitoharju, E., Seppälä, I., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.11.007 · Cited by 628
Cretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1356 · Cited by 616
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90025-x · Cited by 578
Development, Differentiation, and Diversity of Innate Lymphoid Cells
Diefenbach, A., Colonna, M., & Koyasu, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.005 · Cited by 560
Self-citationp46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Lee, J., Zhang, T., Hwang, I., Kim, A., Nitschke, L., Kim, M., Scott, J. M., Kamimura, Y., Lanier, L. L., & Kim, S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.013 · Cited by 552
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1
Gazit, R., Gruda, R., Elboim, M., Arnon, T. I., Katz, G., Achdout, H., Hanna, J., Qimron, U., Landau, G., Greenbaum, E., et al. (2006) · Nature Immunology · doi:10.1038/ni1322 · Cited by 549
Sojka, D. K., Plougastel-Douglas, B., Yang, L., Pak-Wittel, M. A., Artyomov, M. N., Ivanova, Y., Zhong, C., Chase, J. M., Rothman, P. B., Yu, J., et al. (2014) · eLife · doi:10.7554/elife.01659 · Cited by 547
Smyth, M. J., Cretney, E., Takeda, K., Wiltrout, R. H., Sedger, L. M., Kayagaki, N., Yagita, H., & Okumura, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.661 · Cited by 512
MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Walzer, T., Bléry, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S., André, P., Gauthier, L., Daniel, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609692104 · Cited by 476
Xue, L., Salimi, M., Panse, I., Mjösberg, J. M., McKenzie, A. N. J., Spits, H., Klenerman, P., & Ogg, G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.056 · Cited by 475
Crinier, A., Milpied, P., Escalière, B., Piperoglou, C., Galluso, J., Balsamo, A., Spinelli, L., Cervera-Marzal, I., Ebbo, M., Girard-Madoux, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.009 · Cited by 470
Uterine NK cells: active regulators at the maternal-fetal interface
Moffett, A., & Colucci, F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68107 · Cited by 453
Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 452
The glycocalyx and its significance in human medicine
Tarbell, J. M., & Cancel, L. M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12465 · Cited by 440
Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells
Lanier, L. L., Yu, G., & Phillips, J. H. (1989) · Nature · doi:10.1038/342803a0 · Cited by 432
Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice
Bix, M., Liao, N.-S., Zijlstra, M., Loring, J., Jaenisch, R., & Raulet, D. (1991) · Nature · doi:10.1038/349329a0 · Cited by 431
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061287 · Cited by 421
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus
Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-Gross, T., Hanna, J., Nahari, E., et al. (2005) · Nature Immunology · doi:10.1038/ni1190 · Cited by 397
Promiscuity and the single receptor: NKG2D
Eagle, R. A., & Trowsdale, J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2144 · Cited by 374
Pogge von Strandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Böll, B., Simhadri, V. L., Borchmann, P., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.010 · Cited by 374
Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticity
Cella, M., Otero, K., & Colonna, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005641107 · Cited by 350
Self-citationLakshmikanth, T., Burke, S., Ali, T. H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36022 · Cited by 347 · cited 1×
“For example, genetic deficiency of NKp46 in mice results in the impaired clearance of subcutaneous T lymphoma (95) and melanoma (96) tumors and melanoma lung metastases (97, 98).”
BackgroundUp-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
Peppa, D., Gill, U. S., Reynolds, G., Easom, N. J. W., Pallett, L. J., Schurich, A., Micco, L., Nebbia, G., Singh, H. D., Adams, D. H., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121172 · Cited by 342
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Delahaye, N. F., Rusakiewicz, S., Martins, I., Ménard, C., Roux, S., Lyonnet, L., Paul, P., Sarabi, M., Chaput, N., Semeraro, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2366 · Cited by 341
Expression and Function of TNF-Related Apoptosis-Inducing Ligand on Murine Activated NK Cells
Kayagaki, N., Yamaguchi, N., Nakayama, M., Takeda, K., Akiba, H., Tsutsui, H., Okamura, H., Nakanishi, K., Okumura, K., & Yagita, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1906 · Cited by 340
Cortez, V. S., Ulland, T. K., Cervantes-Barragan, L., Bando, J. K., Robinette, M. L., Wang, Q., White, A. J., Gilfillan, S., Cella, M., & Colonna, M. (2017) · Nature Immunology · doi:10.1038/ni.3809 · Cited by 332
Self-citationReprogramming of CTLs into natural killer–like cells in celiac disease
Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L., Tretiakova, M., Semrad, C., Kistner, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060028 · Cited by 322
Peptide Specificity in the Recognition of MHC Class I by Natural Killer Cell Clones
Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A., & Long, E. O. (1995) · Science · doi:10.1126/science.7863326 · Cited by 309
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
Barrow, A. D., Edeling, M. A., Trifonov, V., Luo, J., Goyal, P., Bohl, B., Bando, J. K., Kim, A. H., Walker, J., Andahazy, M., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.037 · Cited by 280
Self-citationChappell, J. D. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.1 · Cited by 278
Simhadri, V. R., Reiners, K. S., Hansen, H. P., Topolar, D., Simhadri, V. L., Nohroudi, K., Kufer, T. A., Engert, A., & Pogge von Strandmann, E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003377 · Cited by 262
Rewiring T-cell responses to soluble factors with chimeric antigen receptors
Chang, Z. L., Lorenzini, M. H., Chen, X., Tran, U., Bangayan, N. J., & Chen, Y. Y. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2565 · Cited by 259
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Deng, W., Gowen, B. G., Zhang, L., Wang, L., Lau, S., Iannello, A., Xu, J., Rovis, T. L., Xiong, N., & Raulet, D. H. (2015) · Science · doi:10.1126/science.1258867 · Cited by 255
Cortez, V. S., Cervantes-Barragan, L., Robinette, M. L., Bando, J. K., Wang, Y., Geiger, T. L., Gilfillan, S., Fuchs, A., Vivier, E., Sun, J. C., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.007 · Cited by 255
Self-citationThe mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46
Arnon, T. I., Achdout, H., Lieberman, N., Gazit, R., Gonen-Gross, T., Katz, G., Bar-Ilan, A., Bloushtain, N., Lev, M., Joseph, A., et al. (2004) · Blood · doi:10.1182/blood-2003-05-1716 · Cited by 253
Exploring the genetic basis of chronic periodontitis: a genome-wide association study
Divaris, K., Monda, K. L., North, K. E., Olshan, A. F., Reynolds, L. M., Hsueh, W.-C., Lange, E. M., Moss, K., Barros, S. P., Weyant, R. J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt065 · Cited by 245
Reiners, K. S., Topolar, D., Henke, A., Simhadri, V. R., Kessler, J., Sauer, M., Bessler, M., Hansen, H. P., Tawadros, S., Herling, M., et al. (2013) · Blood · doi:10.1182/blood-2013-01-476606 · Cited by 239
Correia, D. V., Fogli, M., Hudspeth, K., da Silva, M. G., Mavilio, D., & Silva-Santos, B. (2011) · Blood · doi:10.1182/blood-2011-02-339135 · Cited by 236
Generation of Allospecific Natural Killer Cells by Stimulation Across a Polymorphism of HLA-C
Colonna, M., Brooks, E. G., Falco, M., Ferrara, G. B., & Strominger, J. L. (1993) · Science · doi:10.1126/science.8493555 · Cited by 234
Self-citationTumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Trabanelli, S., Chevalier, M. F., Martinez-Usatorre, A., Gomez-Cadena, A., Salomé, B., Lecciso, M., Salvestrini, V., Verdeil, G., Racle, J., Papayannidis, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00678-2 · Cited by 232
Almeida, A. R., Correia, D. V., Fernandes-Platzgummer, A., da Silva, C. L., da Silva, M. G., Anjos, D. R., & Silva-Santos, B. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0597 · Cited by 229
Properdin: Emerging Roles of a Pattern-Recognition Molecule
Kemper, C., Atkinson, J. P., & Hourcade, D. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101250 · Cited by 228
Glasner, A., Levi, A., Enk, J., Isaacson, B., Viukov, S., Orlanski, S., Scope, A., Neuman, T., Enk, C. D., Hanna, J. H., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.007 · Cited by 222
Rosental, B., Brusilovsky, M., Hadad, U., Oz, D., Appel, M. Y., Afergan, F., Yossef, R., Rosenberg, L. A., Aharoni, A., Cerwenka, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102267 · Cited by 217
Schlecker, E., Fiegler, N., Arnold, A., Altevogt, P., Rose-John, S., Moldenhauer, G., Sucker, A., Paschen, A., von Strandmann, E. P., Textor, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3017 · Cited by 216
Vankayalapati, R., Garg, A., Porgador, A., Griffith, D. E., Klucar, P., Safi, H., Girard, W. M., Cosman, D., Spies, T., & Barnes, P. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4611 · Cited by 215
Farhad, M., Rolig, A. S., & Redmond, W. L. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1434467 · Cited by 212
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice
Barrow, A. D., Raynal, N., Andersen, T. L., Slatter, D. A., Bihan, D., Pugh, N., Cella, M., Kim, T., Rho, J., Negishi-Koga, T., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45913 · Cited by 207
Self-citationTRAIL+ NK Cells Control CD4+ T Cell Responses during Chronic Viral Infection to Limit Autoimmunity
Schuster, I. S., Wikstrom, M. E., Brizard, G., Coudert, J. D., Estcourt, M. J., Manzur, M., O’Reilly, L. A., Smyth, M. J., Trapani, J. A., Hill, G. R., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.013 · Cited by 200
Hammond, E., Khurana, A., Shridhar, V., & Dredge, K. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00195 · Cited by 192
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
Baychelier, F., Sennepin, A., Ermonval, M., Dorgham, K., Debré, P., & Vieillard, V. (2013) · Blood · doi:10.1182/blood-2013-03-489054 · Cited by 186
Tomasello, E., Olcese, L., Vely, F., Geourgeon, C., Bléry, M., Moqrich, A., Gautheret, D., Djabali, M., Mattéi, M., & Vivier, É. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34115 · Cited by 186
Stegmann, K. A., Björkström, N. K., Veber, H., Ciesek, S., Riese, P., Wiegand, J., Hadem, J., Suneetha, P. V., Jaroszewicz, J., Wang, C., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.051 · Cited by 185
Takeda, K., Smyth, M. J., Cretney, E., Hayakawa, Y., Yamaguchi, N., Yagita∥, H., & Okumura, K. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1896 · Cited by 183
Vieillard, V., Strominger, J. L., & Debré, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504315102 · Cited by 183
Garg, A., Barnes, P. F., Porgador, A., Roy, S., Wu, S., Nanda, J. S., Griffith, D. E., Girard, W. M., Rawal, N., Shetty, S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6192 · Cited by 182
Glatzer, T., Killig, M., Meisig, J., Ommert, I., Luetke-Eversloh, M., Babic, M., Paclik, D., Blüthgen, N., Seidl, R., Seifarth, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.013 · Cited by 181
The activating receptor NKp46 is essential for the development of type 1 diabetes
Gur, C., Porgador, A., Elboim, M., Gazit, R., Mizrahi, S., Stern-Ginossar, N., Achdout, H., Ghadially, H., Dor, Y., Nir, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1834 · Cited by 181
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
Pesce, S., Tabellini, G., Cantoni, C., Patrizi, O., Coltrini, D., Rampinelli, F., Matta, J., Vivier, E., Moretta, A., Parolini, S., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1001224 · Cited by 178
Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase
Jarahian, M., Watzl, C., Fournier, P., Arnold, A., Djandji, D., Zahedi, S., Cerwenka, A., Paschen, A., Schirrmacher, V., & Momburg, F. (2009) · Journal of Virology · doi:10.1128/jvi.00211-09 · Cited by 177
Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1
Glasner, A., Ghadially, H., Gur, C., Stanietsky, N., Tsukerman, P., Enk, J., & Mandelboim, O. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102461 · Cited by 176
Hershkovitz, O., Rosental, B., Rosenberg, L. A., Sanchez, M. E. N., Jivov, S., Zilka, A., Gershoni‐Yahalom, O., Brient‐Litzler, E., Bedouelle, H., Ho, J. W. Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802806 · Cited by 176
Allcock, R. J. N., Barrow, A. D., Forbes, S., Beck, S., & Trowsdale, J. (2003) · European Journal of Immunology · doi:10.1002/immu.200310033 · Cited by 173
Self-citationNatural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity
Poirot, L., Benoist, C., & Mathis, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402065101 · Cited by 173
Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44
Fuchs, A., Cella, M., Kondo, T., & Colonna, M. (2005) · Blood · doi:10.1182/blood-2004-12-4802 · Cited by 172
Self-citationMatta, J., Baratin, M., Chiche, L., Forel, J.-M., Cognet, C., Thomas, G., Farnarier, C., Pipéroglou, C., Papazian, L., Chaussabel, D., et al. (2013) · Blood · doi:10.1182/blood-2013-01-481705 · Cited by 170
The extended human leukocyte receptor complex: diverse ways of modulating immune responses
Barrow, A. D., & Trowsdale, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00653.x · Cited by 165
Self-citationEttersperger, J., Montcuquet, N., Malamut, G., Guegan, N., Lopez-Lastra, S., Gayraud, S., Reimann, C., Vidal, E., Cagnard, N., Villarese, P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.018 · Cited by 165
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
Semeraro, M., Rusakiewicz, S., Minard‐Colin, V., Delahaye, N. F., Enot, D. P., Vely, F., Marabelle, A., Papoular, B., Pipéroglou, C., Ponzoni, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa2327 · Cited by 164
Esin, S., Batoni, G., Counoupas, C., Stringaro, A., Brancatisano, F. L., Colone, M., Maisetta, G., Florio, W., Arancia, G., & Campa, M. (2008) · Infection and Immunity · doi:10.1128/iai.00870-07 · Cited by 164
Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1
Halfteck, G. G., Elboim, M., Gur, C., Achdout, H., Ghadially, H., & Mandelboim, O. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801878 · Cited by 162
Hecht, M.-L., Rosental, B., Horlacher, T., Hershkovitz, O., De Paz, J. L., Noti, C., Schauer, S., Porgador, A., & Seeberger, P. H. (2009) · Journal of Proteome Research · doi:10.1021/pr800747c · Cited by 161
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies
Zerafa, N., Westwood, J. A., Cretney, E., Mitchell, S., Waring, P., Iezzi, M., & Smyth, M. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5586 · Cited by 159
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjögren’s Syndrome
Rusakiewicz, S., Nocturne, G., Lazure, T., Semeraro, M., Flament, C., Caillat‐Zucman, S., Sène, D., Delahaye, N., Vivier, É., Chaba, K., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005727 · Cited by 152
A distinct innate lymphoid cell population regulates tumor-associated T cells
Crome, S. Q., Nguyen, L. T., López‐Vergès, S., Yang, S. Y. C., Martin, B. G., Yam, J. Y., Johnson, D. J., Nie, J., Pniak, M., Yen, P. H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4278 · Cited by 151
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
Biroccio, A., Cherfils‐Vicini, J., Augereau, A., Pinte, S., Bauwens, S., Ye, J., Simonet, T., Horard, B., Jamet, K., Cervera, L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2774 · Cited by 150
Chaushu, S., Wilensky, A., Gur, C., Shapira, L., Elboim, M., Halftek, G., Polak, D., Achdout, H., Bachrach, G., & Mandelboim, O. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002601 · Cited by 148
Costa, H. E., Casemayou, A., Aguerre‐Girr, M., Rabot, M., Berrebi, A., Parant, O., Clouet-Delannoy, M., Lombardelli, L., Jabrane‐Ferrat, N., Rukavina, D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3009 · Cited by 145
Li, Y., Wang, Q., & Mariuzza, R. A. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102548 · Cited by 144
Complement factor P is a ligand for the natural killer cell–activating receptor NKp46
Narni-Mancinelli, É., Gauthier, L., Baratin, M., Guia, S., Fenis, A., Deghmane, A., Rossi, B., Fourquet, P., Escalière, B., Kerdiles, Y. M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam9628 · Cited by 144
Zhang, T., Wu, M.-R., & Sentman, C. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103495 · Cited by 141
Wang, W., Guo, H., Geng, J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603464 · Cited by 140
Heparan sulfate as a regulator of inflammation and immunity
Collins, L. E., & Troeberg, L. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0618-246r · Cited by 138
Li, S. S., Kyei, S. K., Timm-McCann, M., Ogbomo, H., Jones, G. J., Shi, M., Xiang, R. F., Oykhman, P., Huston, S. M., Islam, A., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.007 · Cited by 130
Mattiola, I., Pesant, M., Tentorio, P., Molgora, M., Marcenaro, E., Lugli, E., Locati, M., & Mavilio, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500325 · Cited by 126
Nidogens—Extracellular matrix linker molecules
Ho, M. S. P., Böse, K., Mokkapati, S., Nischt, R., & Smyth, N. R. (2008) · Microscopy Research and Technique · doi:10.1002/jemt.20567 · Cited by 124
Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
Jarahian, M., Fiedler, M., Cohnen, A., Djandji, D., Hämmerling, G. J., Gati, C., Cerwenka, A., Turner, P., Moyer, R. W., Watzl, C., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002195 · Cited by 121
Siewiera, J., Gouilly, J., Hocine, H. R., Cartron, G., Levy, C., Al‐Daccak, R., & Jabrane‐Ferrat, N. (2015) · Nature Communications · doi:10.1038/ncomms10183 · Cited by 118
Hudspeth, K. L., Fogli, M., Correia, D. V., Mikulak, J., Roberto, A., Bella, S. D., Silva‐Santos, B., & Mavilio, D. (2012) · Blood · doi:10.1182/blood-2011-11-390153 · Cited by 111
Tissue-Specific Education of Decidual NK Cells
Sharkey, A., Xiong, S., Kennedy, P. R., Gardner, L., Farrell, L. E., Chazara, O., Ivarsson, M. A., Hiby, S. E., Colucci, F., & Moffett, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501229 · Cited by 109
TGF‐β–responsive CAR‐T cells promote anti‐tumor immune function
Hou, A. J., Chang, Z. L., Lorenzini, M. H., Zah, E., & Chen, Y. Y. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10097 · Cited by 106
Seki, N., Hayakawa, Y., Brooks, A. D., Wine, J. W., Wiltrout, R. H., Yagita∥, H., Tanner, J. E., Smyth, M. J., & Sayers, T. J. (2003) · PubMed · Cited by 106
Lilienfeld‐Toal, M. V., Nattermann, J., Feldmann, G., Sievers, E., Frank, S., Strehl, J., & Schmidt‐Wolf, I. G. H. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03078.x · Cited by 104
Molecular definition of group 1 innate lymphoid cells in the mouse uterus
Filipovic, I., Chiossone, L., Vacca, P., Hamilton, R. S., Ingegnere, T., Doisne, J., Hawkes, D., Mingari, M. C., Sharkey, A., Moretta, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06918-3 · Cited by 102
Wilkens, J., Male, V., Ghazal, P., Forster, T., Gibson, D. A., Williams, A. R. W., Brito-Mutunayagam, S. L., Craigon, M., Lourenco, P., Cameron, I. T., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300958 · Cited by 101
Esin, S., Counoupas, C., Aulicino, A., Brancatisano, F. L., Maisetta, G., Bottai, D., Luca, M. D., Florio, W., Campa, M., & Batoni, G. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12052 · Cited by 100
Inhibition of Human Natural Killer Cell Activity by Influenza Virions and Hemagglutinin
Mao, H., Tu, W., Liu, Y.-P., Qin, G., Zheng, J., Chan, P., Lam, K.-T., Peiris, J. M. M., & Lau, Y.-L. (2010) · Journal of Virology · doi:10.1128/jvi.02340-09 · Cited by 100
Cantoni, C., Ponassi, M., Biassoni, R., Conte, R., Spallarossa, A., Moretta, A., Moretta, L., Bolognesi, M., & Bordo, D. (2003) · Structure · doi:10.1016/s0969-2126(03)00095-9 · Cited by 100
Pazina, T., Shemesh, A., Brusilovsky, M., Porgador, A., & Campbell, K. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00369 · Cited by 98
Lebbink, R. J., Raynal, N., Ruiter, T. E.-D., Bihan, D. G., Farndale, R. W., & Meyaard, L. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.03.005 · Cited by 97
Chemical Tumor Biology of Heparan Sulfate Proteoglycans
Raman, K., & Kuberan, B. (2010) · Current Chemical Biology · doi:10.2174/187231310790226206 · Cited by 97
Vitenshtein, A., Charpak-Amikam, Y., Yamin, R., Bauman, Y., Isaacson, B., Stein, N., Berhani, O., Dassa, L., Gamliel, M., Gur, C., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.09.008 · Cited by 96
Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production
Salimi, M., Xue, L., Jolin, H. E., Hardman, C. S., Cousins, D. J., McKenzie, A. N. J., & Ogg, G. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501102 · Cited by 96
Germ‐line and rearranged Tcrd transcription distinguish bona fide NK cells and NK‐like γδ T cells
Stewart, C. A., Walzer, T., Robbins, S. H., MALISSEN, B., Vivier, É., & Prinz, I. (2007) · European Journal of Immunology · doi:10.1002/eji.200737354 · Cited by 92
Li, S. S., Ogbomo, H., Mansour, M. K., Xiang, R. F., Szabo, L., Munro, F., Mukherjee, P. G., Mariuzza, R. A., Amrein, M., Vyas, J. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03014-4 · Cited by 91
Selective cross‐talk among natural cytotoxicity receptors in human natural killer cells
Augugliaro, R., Parolini, S., Castriconi, R., Marcenaro, E., Cantoni, C., Nanni, M., Moretta, L., Moretta, A., & Bottino, C. (2003) · European Journal of Immunology · doi:10.1002/eji.200323896 · Cited by 88
Carbone, T., Nasorri, F., Pennino, D., Eyerich, K., Foerster, S., Cifaldi, L., Traidl‐Hoffmann, C., Behrendt, H., & Cavani, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902518 · Cited by 88
Costa, H. E., Tabiasco, J., Berrebi, A., Parant, O., Aguerre‐Girr, M., Piccinni, M., & Bouteiller, P. P. L. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.06.123 · Cited by 86
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor
Gaggero, S., Bruschi, M., Petretto, A., Parodi, M., Zotto, G. D., Lavarello, C., Prato, C., Santucci, L., Barbuto, A., Bottino, C., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1470730 · Cited by 84
Brondijk, T. H. C., Ruiter, T. E.-D., Ballering, J., Wienk, H., Lebbink, R. J., van Ingen, H., Boelens, R., Farndale, R. W., Meyaard, L., & Huizinga, E. G. (2009) · Blood · doi:10.1182/blood-2009-10-246322 · Cited by 76
Joyce, M. G., Tran, P., Zhuravleva, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100622108 · Cited by 76
Cutting Edge: Human CD49e− NK Cells Are Tissue Resident in the Liver
Yeang, H. X. A., Piersma, S. J., Lin, Y., Yang, L., Malkova, O. N., Miner, C. A., Krupnick, A. S., Chapman, W. C., & Yokoyama, W. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601818 · Cited by 76
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human
Yu, J., Mitsui, T., Wei, M., Mao, H. C., Butchar, J. P., Shah, M. V., Zhang, J., Mishra, A., Alvarez-Breckenridge, C. A., Liu, X., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43242 · Cited by 74
Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D
Nordkamp, M. J. M. O., van Eijk, M., Urbanus, R. T., Bont, L., Haagsman, H. P., & Meyaard, L. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ab0213-092rr · Cited by 73
Mantovani, S., Oliviero, B., Lombardi, A., Varchetta, S., Mele, D., Sangiovanni, A., Rossi, G. E., Donadon, M., Torzilli, G., Soldani, C., et al. (2018) · Hepatology · doi:10.1002/hep.30235 · Cited by 73
Vivier, É., da Silva, A. J., Ackerly, M., Levine, H., Rudd, C. E., & Anderson, P. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230821 · Cited by 72
Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β
Alba, A., Planas, R., Clemente, X., Carrillo, J., Ampudia, R. M., Puertas, M. C., Pastor, X., Tolosa, E., Pujol‐Borrell, R., Verdaguer, J., et al. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03580.x · Cited by 71
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity
Wu, M.-R., Zhang, T., Gacerez, A. T., Coupet, T. A., DeMars, L. R., & Sentman, C. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402517 · Cited by 70
Horton, N., & Mathew, P. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00031 · Cited by 69
Correia, M. P., Stojanovic, A., Bauer, K., Juraeva, D., Tykocinski, L., Lorenz, H., Brors, B., & Cerwenka, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720564115 · Cited by 69
Horton, N., Mathew, S. O., & Mathew, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059552 · Cited by 67
Hershkovitz, O., Jarahian, M., Zilka, A., Bar-Ilan, A., Landau, G., Jivov, S., Tekoah, Y., Lichtenstein, R. G., Gallagher, J. T., Hoffmann, S. C., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm125 · Cited by 64
Rusakiewicz, S., Perier, A., Semeraro, M., Pitt, J. M., von Strandmann, E. P., Reiners, K. S., Aspeslagh, S., Pipéroglou, C., Vely, F., Ivagnès, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1137418 · Cited by 64
BAG-6, a jack of all trades in health and disease
Binici, J., & Koch, J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1522-y · Cited by 63
B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity
Wu, M.-R., Zhang, T., DeMars, L. R., & Sentman, C. L. (2015) · Gene Therapy · doi:10.1038/gt.2015.29 · Cited by 63
Sheppard, S., Schuster, I. S., Andoniou, C. E., Cocita, C., Adejumo, T., Kung, S. K. P., Sun, J. C.-Y., Degli‐Esposti, M. A., & Guerra, N. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.023 · Cited by 63
Rouzaire, P., Luci, C., Blasco, E., Bienvenu, J., Walzer, T., Nicolas, J., & Hennino, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141820 · Cited by 59
Barrow, A. D., Palarasah, Y., Bugatti, M., Holehouse, A. S., Byers, D. E., Holtzman, M. J., Vermi, W., Skjødt, K., Crouch, E. C., & Colonna, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402289 · Cited by 58
Self-citationPhenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells
Verrier, T., Satoh‐Takayama, N., Serafini, N., Marie, S., Santo, J. P. D., & Vosshenrich, C. A. J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502673 · Cited by 57
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
Textor, S., Bossler, F., Henrich, K., Gartlgruber, M., Pollmann, J., Fiegler, N., Arnold, A., Westermann, F., Waldburger, N., Breuhahn, K., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1116674 · Cited by 56
Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells
Dietrich, J., Nakajima, H., & Colonna, M. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00294-x · Cited by 53
Self-citationCellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G
Eagle, R. A., Flack, G., Warford, A., Martínez-Borra, J., Jafferji, I., Traherne, J. A., Ohashi, M., Boyle, L. H., Barrow, A. D., Caillat‐Zucman, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004503 · Cited by 53
Self-citationRIG-I activation induces the release of extracellular vesicles with antitumor activity
Daßler-Plenker, J., Reiners, K., van den Boorn, J. G., Hansen, H., Putschli, B., Barnert, S., Schuberth-Wagner, C., Schubert, R., Tüting, T., Hallek, M., et al. (2016) · Oncoimmunology · doi:10.1080/2162402x.2016.1219827 · Cited by 53
Expression of Ligands to NKp46 in Benign and Malignant Melanocytes
Cagnano, E., Hershkovitz, O., Zilka, A., Bar-Ilan, A., Golder, A., Sion‐Vardy, N., Bogdanov‐Berezovsky, A., Mandelboim, O., Benharroch, D., & Porgador, A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701111 · Cited by 51
Tang, Q., Grzywacz, B. J., Wang, H., Kataria, N., Cao, Q., Wagner, J. E., Blazar, B. R., Miller, J. S., & Verneris, M. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4507 · Cited by 51
Kellner, C., Maurer, T., Hallack, D., Repp, R., van de Winkel, J. G. J., Parren, P. W. H. I., Valerius, T., Humpe, A., Gramatzki, M., & Peipp, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201321 · Cited by 51
Binici, J., Hartmann, J., Herrmann, J. E., Schreiber, C., Beyer, S., Güler, G., Vogel, V., Tumulka, F., Abele, R., Mäntele, W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.483602 · Cited by 50
Exploiting NK Cell Surveillance Pathways for Cancer Therapy
Barrow, A., & Colonna, M. (2019) · Cancers · doi:10.3390/cancers11010055 · Cited by 48
Self-citationBensussan, A., Remtoula, N., Sivori, S., Bagot, M., Moretta, A., & Marie‐Cardine, A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.404 · Cited by 47
Charpak‐Amikam, Y., Kubsch, T., Seidel, E., Oiknine‐Djian, E., Cavaletto, N., Yamin, R., Schmiedel, D., Wolf, D. G., Gribaudo, G., Messerle, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08866-2 · Cited by 47
Natural killer cell mediated immunosurveillance of pediatric neuroblastoma
Semeraro, M., Rusakiewicz, S., Zitvogel, L., & Kroemer, G. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1042202 · Cited by 46
Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia
Freud, A. G., Zhao, S., Wei, S., Gitana, G., Molina-Kirsch, H. F., Atwater, S. K., & Natkunam, Y. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpwgg69mczowmm · Cited by 46
Willumsen, N., Bager, C. L., Leeming, D. J., Bay‐Jensen, A., & Karsdal, M. A. (2017) · Neoplasia · doi:10.1016/j.neo.2017.01.008 · Cited by 42
Merzoug, L. B., Marie, S., Satoh‐Takayama, N., Lesjean, S., Albanesi, M., Luche, H., Fehling, H. J., Santo, J. P. D., & Vosshenrich, C. A. J. (2014) · European Journal of Immunology · doi:10.1002/eji.201444643 · Cited by 38
Kellner, C., Guenther, A., Humpe, A., Repp, R., Klausz, K., Derer, S., Valerius, T., Ritgen, M., Brüggemann, M., van de Winkel, J. G. J., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1058459 · Cited by 38
Haywood, J., Qi, J., Chen, C., Lu, G., Liu, Y., Yan, J., Shi, Y., & Gao, G. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522572113 · Cited by 38
Peipp, M., Derer, S., Lohse, S., Staudinger, M., Klausz, K., Valerius, T., Gramatzki, M., & Kellner, C. (2015) · Oncotarget · doi:10.18632/oncotarget.5135 · Cited by 38
Survival in acute myeloid leukemia is associated with NKp44 splice variants
Shemesh, A., Brusilovsky, M., Hadad, U., Teltsh, O., Edri, A., Rubin, E., Campbell, K. S., Rosental, B., & Porgador, A. (2016) · Oncotarget · doi:10.18632/oncotarget.8782 · Cited by 38
Schmiedel, D., Tai, J., Levi-Schaffer, F., Dovrat, S., & Mandelboim, O. (2016) · Journal of Virology · doi:10.1128/jvi.01164-16 · Cited by 38
Tailoring Natural Killer cell immunotherapy to the tumour microenvironment
Barrow, A. D., & Colonna, M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.001 · Cited by 38
Self-citationNKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression
Turchinovich, G., Ganter, S., Bärenwaldt, A., & Finke, D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701333 · Cited by 37
Polymerase δ-interacting Protein 2: A Multifunctional Protein
Hernandes, M. S., Lassegue, B. P., & Griendling, K. K. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000465 · Cited by 34
Surveillance of cell and tissue perturbation by receptors in the LRC
Trowsdale, J., Jones, D. C., Barrow, A., & Traherne, J. (2015) · Immunological Reviews · doi:10.1111/imr.12314 · Cited by 33
Self-citationJang, Y., Gerbec, Z. J., Won, T., Choi, B., Podsiad, A. B., Moore, B. B., Malarkannan, S., & Laouar, Y. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701676 · Cited by 32
An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities
Tal, Y., Yaakobi, S., Horovitz‐Fried, M., Safyon, E., Rosental, B., Porgador, A., & Cohen, C. J. (2014) · Oncotarget · doi:10.18632/oncotarget.1919 · Cited by 30
Wang, Y., Yuan, W., Guo, H., & Jiang, Y. (2014) · Autoimmunity · doi:10.3109/08916934.2014.990629 · Cited by 27
Eisenberg, V., Shamalov, K., Meir, S., Hoogi, S., Sarkar, R., Pinker, S., Markel, G., Porgador, A., & Cohen, C. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01212 · Cited by 26
Yossef, R., Gur, C., Shemesh, A., Guttman, O., Hadad, U., Nedvetzki, S., Miletić, A., Nalbandyan, K., Cerwenka, A., Jonjić, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118936 · Cited by 25
Berhani, O., Glasner, A., Kahlon, S., Duev‐Cohen, A., Yamin, R., Horwitz, E. P., Enk, J., Moshel, O., Varvak, A., Porgador, A., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847611 · Cited by 25
NKp44 expression, phylogenesis and function in non-human primate NK cells
Maria, A. D., Ugolotti, E., Rutjens, E., Mazza, S., Radic, L., Faravelli, A., Koopman, G., Marco, E. D., Costa, P., Ensoli, B., et al. (2009) · International Immunology · doi:10.1093/intimm/dxn144 · Cited by 24
Innate lymphoid cell sensing of tissue vitality
Barrow, A. D., & Colonna, M. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.11.004 · Cited by 24
Self-citationKIR haplotypes are associated with late-onset type 1 diabetes in European–American families
Traherne, J., Jiang, W., Valdés, A., Hollenbach, J., Jayaraman, J., Lane, J. A., Johnson, C. L., Trowsdale, J., & Noble, J. A. (2015) · Genes and Immunity · doi:10.1038/gene.2015.44 · Cited by 22
NK‐cell receptors NKp46 and NCR1 control human metapneumovirus infection
Diab, M., Glasner, A., Isaacson, B., Bar‐On, Y., Drori, Y., Yamin, R., Duev‐Cohen, A., Danziger, O., Zamostiano, R., Mandelboim, M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646756 · Cited by 22
Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression
Glasner, A., Isaacson, B., Viukov, S. V., Neuman, T., Friedman, N., Mandelboim, M., Sexl, V., Hanna, J. H., & Mandelboim, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-12998-w · Cited by 22
NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint
Shemesh, A., Kugel, A., Steiner, N., Yezersky, M., Tirosh, D., Edri, A., Teltsh, O., Rosental, B., Sheiner, E., Rubin, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12292 · Cited by 20
β1 Integrins Are Required To Mediate NK Cell Killing of Cryptococcus neoformans
Xiang, R. F., Li, S. S., Ogbomo, H., Stack, D., & Mody, C. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701805 · Cited by 16
McQuaid, S., Loughran, S. T., Power, P., Maguire, P. T., Walls, D., Cusi, M. G., Örvell, C., & JOHNSON, P. A. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001070 · Cited by 11
Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation
Goldman, S. E., Moshkovits, I., Shemesh, A., Filiba, A., Tsirulsky, Y., Vronov, E., Shagan, M., Apte, R. N., Benharroch, D., Karo‐Atar, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160779 · Cited by 10
Cited by
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
“CLA, cutaneous lymphocyte-associated antigen; CCR8, C-C motif chemokine receptor 8; GATA3, GATA binding protein 3; CXCR6, C-XC motif chemokine receptor 6; KIR, killer cell immunoglobulin-like receptor; CILCP, common innate-like cell precursor NKp44), receptors recognizing non-self-antigens (Ly49H) and other receptors…”
NK cell-based cancer immunotherapy: from basic biology to clinical development
Liu, S., Galat, V., Galat4, Y., Lee, Y. K. A., Wainwright, D., & Wu, J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01014-w · Cited by 689
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Bald, T., Krummel, M. F., Smyth, M. J., & Barry, K. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0728-z · Cited by 506
Metadata
- Authors
- Barrow, A. D., Martin, C. J., & Colonna, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-05-07
- Volume
- 10
- Pages
- 909-909
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2944519468
- Cited by
- 370
- References
- 195
- FWCI
- 14.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.